A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Clinical trial NCT02723994 · COMPLETED
Trial details
- NCT number
- NCT02723994
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2026-03-03
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.